Tenaya Therapeutics Inc (TNYA)
4.65
+0.40
(+9.41%)
USD |
NASDAQ |
May 17, 16:00
4.65
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Total Liabilities (Quarterly): 26.72M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 26.72M |
| December 31, 2023 | 31.09M |
| September 30, 2023 | 28.51M |
| June 30, 2023 | 30.81M |
| March 31, 2023 | 29.93M |
| December 31, 2022 | 35.57M |
| September 30, 2022 | 29.98M |
| Date | Value |
|---|---|
| June 30, 2022 | 32.06M |
| March 31, 2022 | 32.40M |
| December 31, 2021 | 35.66M |
| September 30, 2021 | 28.10M |
| June 30, 2021 | 265.43M |
| March 31, 2021 | 253.70M |
| December 31, 2020 | 229.48M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
26.72M
Minimum
Mar 2024
265.43M
Maximum
Jun 2021
77.82M
Average
31.58M
Median
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 82.48B |
| Solid Biosciences Inc | 38.46M |
| Dyne Therapeutics Inc | 44.22M |
| Sana Biotechnology Inc | 306.24M |
| Prime Medicine Inc | 67.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 184.90M |
| Shareholders Equity (Quarterly) | 158.18M |